Afasevikumab Uses, Dosage, Side Effects and more
Afasevikumab is under investigation in clinical trial NCT01480310 (Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of Subcutaneous MCAF5352A in Healthy Volunteers).
| Attribute | Details |
|---|---|
| Trade Name | Afasevikumab |
| Generic | Afasevikumab |
| Afasevikumab Other Names | Afasevikumab, MCAF5352A |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
